etoposide has been researched along with Atelectasis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berdel, WE; Diehl, V; Graubner, M; Gropp, C; Klippstein, TH; Mende, S; Mitrou, PS | 1 |
Akiyama, Y; Fujino, M; Kawakami, Y; Kirisawa, T; Naya, Y; Ohe, M | 1 |
2 other study(ies) available for etoposide and Atelectasis
Article | Year |
---|---|
cis-Platinum (DDP) and VP 16-213 (etoposide) combination chemotherapy for advanced non-small cell lung cancer. A phase II clinical trial.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Carcinoma, Squamous Cell; Cisplatin; Drug Evaluation; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Pulmonary Atelectasis; Time Factors | 1984 |
[A case of primary endobronchial mucosa-associated lymphoid tissue lymphoma with middle lobe atelectasis].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, B-Cell, Marginal Zone; Methotrexate; Middle Aged; Pulmonary Atelectasis; Remission Induction; Vincristine | 1997 |